chrisvoncsefalvay/vaers-outcomes huggingface dataset:
i was nautious for a month after, tired, went into anaphylactic shock for the first time ever. i am now experiencing numbness and tingling in my right  toes
Sharp headache, fever, muscle pain (very sharp pain in the legs), loss of appetite, stomach pain, chills, sleepiness, severe pain in the arm of the vaccine, thirst, constant desire to urinate.
Client was a foreign exchange student living in area. Address and phone number listed above was the residence and phone she had while in the area. When she returned back to her home country recently she was hospitalized with a "blood disorder". Medical records state pancytopenia. msv
muscle aches, fatigue, joint pain, headaches, abdominal pain, mild nausea
Pt describes - burn at injection site about 1 minute after then back began to tighten by 20 minutes post injection pain 8/10 and worse with deep breath also initial burning into left arm to finger tips.
Patient with low grade fever, new runny nose, nasal congestion consistent with SXS that of FLUMIST.
Initial report received from the patient who is a health care professional on 24 January 2011. A 56 year-old female patient who had no concurrent illnesses, but who has environmental allergies (unspecified) and an unspecified right foot injury, had received an intramuscular deltoid injection of FLUZONE (unspecified as lot number was not reported) on 12 November 2010 and the next day woke up with her eyes crusted over. She subsequently developed a runny nose that lasted 1 week, and then a week later developed bronchitis. The patient required a physician visit; however results of that visit were not provided as well as treatments received. At the time of this report, the patient had not fully recovered, specified as "eyes still" (incomplete sentence). Documents held by sender: None.
Information has been received from a RN concerning a 58 yr old female physician who on 16Aug05 was vaccinated with a dose of pneumococcal 23v polysaccharide vaccine (lot 6499989/0579P), IM in the left deltoid. On 16Aug05 the pt developed severe pain, redness and swelling in left arm. There was severe swelling, redness and a large blister noted at the injection site the following AM. The symptoms began a few hrs after receiving the injection. The physician recovered. It was also reported that another adult pt had an adverse experience after being vaccinated with pneumococcal 23v polysaccharide vaccine (WAES0508USA03733). No further information is expected.
injection site warm to the touch; white areas around injection area; redness around injection site; This spontaneous case was reported by a health care professional and describes the occurrence of VACCINATION SITE WARMTH (injection site warm to the touch), VACCINATION SITE DISCOLOURATION (white areas around injection area) and VACCINATION SITE ERYTHEMA (redness around injection site) in a 24-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Jan-2021, the patient experienced VACCINATION SITE WARMTH (injection site warm to the touch), VACCINATION SITE DISCOLOURATION (white areas around injection area) and VACCINATION SITE ERYTHEMA (redness around injection site). At the time of the report, VACCINATION SITE WARMTH (injection site warm to the touch), VACCINATION SITE DISCOLOURATION (white areas around injection area) and VACCINATION SITE ERYTHEMA (redness around injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported. No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 17-Apr-2021: No new information
This is a 54y.o. female with past medical history significant for an MI in 2010, COPD, diabetes type 2, hypokalemia, and hypertension. She presents today for evaluation of various concerns. She states that she has had shortness of breath for approximately 2-3 days. She also notes associated body aches, subjective fever and chills. She does note a cough that is nonproductive in nature. She states that she has tried her inhalers without relief. She denies any orthopnea. Does admit to occasional chest tightness early with coughing. She states that the sensation is distinctly different from prior MI. Denies any recent increase in lower extremity swelling. Patient is not on supplemental oxygen at baseline. Patient denies smoking history. Patient states that she was vaccinated for covid with Johnson & Johnson vaccine and May 2021. Denies booster vaccination. States that 2 other family members were recently diagnosed with Covid and have similar symptoms to her. Also does endorse recent change in urination pattern. She states that her urine over the past 2-3 days has been bloody. Also notes a fall smelling urine. Denies any history of urinary tract infections. Denies any recent use of antibiotics. Does admit to dysuria. Admits to low back pain as well.
Site: Itching at Injection Site-Severe, Site: Redness at Injection Site-Severe, Site: Swelling at Injection Site-Severe, Systemic: Allergic: Itch (specify: facial area, extremities)-Severe, Systemic: Allergic: Itch Generalized-Severe, Systemic: Allergic: Rash (specify: facial area, extremities)-Severe, Systemic: Allergic: Rash Generalized-Severe, Systemic: Allergic: Swelling of Face/Eyes/Mouth/Tongue-Severe, Systemic: Diarrhea-Severe, Systemic: Dizziness/Lightheadedness-Severe, Systemic: headache, numbness and tingling in extremities, could not sleep-Severe, Systemic: Headache-Severe, Systemic: Numbness (specify: facial area, extremities)-Severe, Systemic: Tingling (specify: facial area, extremities)-Severe, Systemic: Unable to Sleep-Medium, Additional details: Patient reported to pharmacy today, 8/31/2022, regarding an adverse effect(s). She contacted MD on 02/24/2022.
Patient's wife said the patient developed chills and was feeling really cold around 9PM on 9/4/2020. They wrapped a blanket around him to keep him warm. She said he then began to projectile vomit. After he was over that they took his temperature and it was 103.0 at 11:30pm. Then a short time later it was up to 105.0 at which point they called an ambulance. The ambulance arrived and stabilized his temperature. She was not aware of the time of that though. His fever was gone by the next day. He felt week until 9/9/2020. On 9/9/2020 he developed cold sores. As of 9/12/2020 the cold sores are still present.
Pain radiating from site both up and down arm, limited range of motion, inability to pick up heavy objects reported by patient.  No treatment sought and it did not appear she would seek treatment.
I had my first shot on 3/25 of Pfizer not much reaction arm was a little sore, headache and some nausea.  Forward to 2nd shot on 4/16 arm was sore then 3_4 days out started having night sweats, headaches every day. Day 11 increased blood pressures throughout the day escalating to 198/98 at home went to ER and they escalated to over 200/100. Now mind you prior to all of this my BP'S ranged from low teens to maybe mid 130's with pain. I'm now on BP medication that I did not have to take before.
Skin looks yellowish; Huge pain/ She describes her pain as 5 out 10; Tenderness and reddish skin after vaccinated; Tenderness and reddish skin after vaccinated; Arm sensitivity at site of injection; This spontaneous case was received on 22-Sep-2020 from a pharmacist via agency (reference number: SEQW20-02129) and concerned a female patient of unspecified age.  The medical history and concomitant medications of the patient were not reported. The historical vaccines included flu vaccines with no adverse reactions after their administration.  On an unspecified date, the patient was vaccinated with Fluad Quadrivalent (influenza vaccine, inactivated influenza virus surface antigen (subunit), egg-derived, MF59, indication, dose, route of administration and anatomical location: not reported). The batch number and expiry date were not reported.   On the same day, after receiving Fluad Quadrivalent, the patient experienced huge pain. The patient did not take any pain killer.   On an unspecified date, after receiving Fluad Quadrivalent, the patient developed tenderness and reddish skin after getting vaccinated. The patient described the pain as 5 out 10.   On an unspecified date, four weeks after receiving Fluad Quadrivalent, the patient complained about arm sensitivity at site of the injection and skin which looked yellowish.    At the time of initial reporting on 22-Sep-2020, the outcome of the events was not reported.  The reporter did not provide a causality assessment.  Company comment: Yellow skin, pain, tenderness, erythema and vaccination site pain were associated with the use of the suspect product Fluad Quadrivalent. Chronology needs more clarification for all events. The medical history and concomitant medications of the patient were not reported and the historical vaccines included flu vaccines with no adverse reactions after their administration. With information presented, causality is assessed as possibly related for all events since narrative suggests that all event occurred on the vaccinted arm.; Sender's Comments: Yellow skin, pain, tenderness, erythema and vaccination site pain were associated with the use of the suspect product Fluad Quadrivalent. Chronology needs more clarification for all events. The medical history and concomitant medications of the patient were not reported and the historical vaccines included flu vaccines with no adverse reactions after their administration. With information presented, causality is assessed as possibly related for all events since narrative suggests that all event occurred on the vaccinted arm.
Fatigue started around 4 hours after vaccination. Headache, body aches and chills started 2 hours after fatigue. All symptoms subsided around 36 hours after vaccination.
Information has been received from a nurse practitioner concerning a 17 year old female patient who on 25-AUG-2008 was vaccinated with the first dose of GARDASIL (lot# 0053X). There was no concomitant medication. It was reported that the patient fainted 1 to 2 minutes after receiving the dose. Patient hit her face on the wall and broke her nose which was considered to be disabling. Patient sought medical attention with the nurse practitioner. Additional information has been requested.
irritated lungs; hard time breathing; it was hurting my chest; it 'urges' inflammation of the lining around the lungs/ Get too much allergens so I have an inflammation of the lungs, irritation; got this allergy from ground, wind, tree and grasses/Inflammation; allergies from wind, leaves and trees; allergies from wind, leaves and trees; This is a spontaneous report from a contactable consumer (patient). A 70-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Formulation: Solution for injection, Lot number: EN6199, Expiration Date: not reported), via an unspecified route of administration in left deltoid on an unspecified date as dose 1, single for COVID-19 immunization (at the age of 70-year-old). The patient medical history was not reported. The patient's concomitant medications were not reported. Patient experienced congestion, irritated lungs and hard time breathing. Patient was scheduled to receive the second dose this Friday 02Apr2021. Over the weekend he had allergies from wind, leaves and trees and his lungs got inflamed and this caused irritation of the lining of his lungs, he was not on medication. Patient got too much allergens from air which had a lot of dust, grasses coming out while working on the field, so he had an inflammation of the lungs, irritation and on the Saturday he went to the doctor because it was hurting his chest and it 'urges' inflammation of the lining around the lungs probably from air allergens or something like that and they checked everything and did not prescribed any medication. Everything was normal, everything was good. Patient had no problem with the vaccine and got this allergy from ground, wind, tree and grasses. He consulted his doctor and pharmacist and had no answer, they did not know well but they did not think there would be any problem but it might not be as effective; patient mentioned that he would hate to cancel his appointment for the second dose this weekend, because it was very difficult to reschedule it. Patient wanted to know if his irritated lungs would interfere with the second dose of the vaccine (efficacy) whether he should take it or not. The patient underwent lab tests and procedures which included blood test, chest x-ray and electrocardiogram was normal on an unspecified date. The outcome of the events was unknown.  No follow-up attempts are needed. No further information is expected.  Follow-up attempts are completed. No further information is expected.
?Pfizer-BioNTech COVID-19 Vaccine EUA?  I noticed significantly lowered heartrate following the vaccine administration.  My average resting rate is 79 bpm, but on the 2nd night following the shot, my heart rate fell into the 30's for several days (shot on March 1, sleeping heart rate substantially drops at night March 3-7).
On the day following receipt of vaccine pt had shoulder pain which got worse.   The following morning she had left sided facial numbness and droop.   Pt is at stated 17 weeks gestation.  EDC  August 10, 2021.  LMP 11/4/220.  Pt is Primigravid.  She, at the time of ED visit did not have any pregnancy related problem.
Narrative: COVID infection following COVID vaccine series 02/17, Pfizer, dose #1 03/10, Pfizer, dose #2 10/20, Pfizer, dose #3 09/19 10/15 COVID swab, result: NOT detected 09/22 pt cc: chills, cough, diarrhea, fatigue, fever, headache, loss of taste or smell, myalgias, nausea, rhinorrhea dyspnea, sore throat vomiting exposure: unknown 09/22 COVID swab, result: detected 10/12 COVID swab, result: NOT detected 10/15 COVID swab, result: NOT detected
Patient has no adverse reaction to the high dose Fluzone vaccine. Patient stated he was feeling fine and did not report any symptom. Patient was advised to seek PCP if symptoms occurred.
Became very tired and had to go to bed by 6:15 p.m. on date of 2nd injection woke up with chills fever body hurting really bad Friday night went to work Saturday morning had to leave after 3 hours very sick body aching couldn't hardly move my neck fever chills went to bed was in bed all day Saturday All night Saturday night the fever broke Sunday morning still very tired could only be up for a short time before having the lay back down. Slap half the day Sunday Sunday night primarily just a headache and a mild cough And being very tired as of today Monday.
Approximately a few hours after my vaccination I experienced the following symptoms: Insomnia, Headaches, Loss of muscle tone all over my body. I took some sleeping pills to help with my insomnia, but it did not help at all. I went to the doctor for consultation, and they cannot determine where I got my insomnia, and I was prescribed with Ambien and other medications that would help with my sleep pattern but nothing seemed to help. Up to this day I still experience insomnia and extreme anxiety.
pt states that a couple of hours after taking the vax she started having heart palpitations like her heart was pumping very hard and she felt really strange.  She went to her PCP on 3/30/2021.  They did blood work with pending results and EKG is normal.  Pt still has these symptoms with heart palpitations but her bpm is normal.  She is concerned about getting 2nd dose.
Patient came to our pharmacy to get COVID booster vaccine ( moderna). We went through the questionnaires and found no problem so we gave the vaccine. Later, we were contacted by a family member. Daughter said she had  gotten the booster 2 days ago and told us patient has memory problems.  Patient received 2 doses of 0.25ml Moderna booster 2 days apart.
Adverse reaction to GARDASIL vaccine. 9 year old healthy college athlete has missed a year of school and been extremely ill with autoimmune diseases, chronic EBV, massive face and body swelling, personality change, menstrual change since receiving the second of 2 GARDASIL vaccines.
Inadvertent administration of Covid vaccine (Orange Cap) for 5-11 years to patient who should have received Covid Maroon cap since age 4 years. Contacted parent, no adverse events or symptoms observed. Declines enrollment in V-safe. States will observe patient and notify clinic if any symptoms develop.
This case was extracted from the VAERS database via QSCAN on 11 March 2009 (reference number 294643). A 57-year-old male patient received an intramuscular injection of FLUZONE 2007-2008 (lot number U2526AA) on 26 October 2007. Approximately four hours post-vaccination, the patient developed a mild cough with throat irritation. Five hours post-vaccination, his neck felt swollen and he experienced numbness below the corners of his mouth. He developed red eyes with yellow discharge, and generalized achy feeling in his legs. He took 50mg diphenhydramine, and had symptomatic relief. The following morning he had ongoing throat thickness, and he took 25mg of diphenenhydramine. Symptoms resolved.
High fever, highest was 102.5, lowest is 101.5. Body aches and bad headache, chills, nausea, pain every where.
Still fighting shingles in eye; Broke out with shingles; This case was reported by a consumer via interactive digital media and described the occurrence of ophthalmic herpes zoster in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, less than a year after receiving Shingles vaccine, the patient experienced ophthalmic herpes zoster (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the ophthalmic herpes zoster was not recovered/not resolved and the outcome of the shingles was unknown.   It was unknown if the reporter considered the ophthalmic herpes zoster and shingles to be related to Shingles vaccine.     Additional Information: GSK Receipt Date: 19-SEP-2022 Reporter's Comment: This case was reported by a patient via interactive digital media. The patient received dose of Shingles vaccine and the next day he/she broke out with shingles still fighting it in his/her eye one year later. The patient stated that do not get the vaccine whatever you do. Additional supportive information: The follow-up would not possible, as no contact, details were available.
achiness; fever; vomiting; palpitations; breathing heavy; This is a spontaneous report from a contactable consumer, the patient. A male patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, lot number: unknown), via an unspecified route of administration on 04May2021 as dose 1, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. It was reported that after receiving his first injection of the Pfizer COVID-19 vaccine yesterday on 04May2021. He reported he also experienced palpitations and breathing heavy shortly after the Pfizer COVID-19 injection but those were better now. On unknown date, he was experiencing achiness, fever, and vomiting. The patient questioned that were the side effects worsened after second injection. The outcome of the events achiness, fever, vomiting was unknown while outcome of the events palpitations and breathing heavy was recovering.  No follow up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Information has been received from a registered nurse concerning a 4 year old male with no allergies who on 9/4/03 was vaccinated with a dose of hepatitis A virus vaccine inactivated (lot # 646423/0500N). On approximately 9/4/03 the patient developed 5 generalized small raised bumps which were1/2 inch diameter and felt warm. The patient recovered in a few days. Unspecified medical attention was sought. There was no product quality complaint. The nurse also reported that the patient was vaccinated on 11/3/03 with a first dose of MMR vaccine (lot # 644843/1229M) administered SC in the left and a fourth dose of poliovirus vaccine inactivated (batch # W1156) and the patient had a similar reaction. No further information is expected.
pt recv vax 24JUL95 & 10JUL96 pt exp full blown varicella;
Patient broke out in hives on arms and chest.  Was given Benadryl and observed.  Was sent home after improvement.  Counselled on pre-medication with Benadryl prior to dose #2.
Arm became red, welted and hot to touch. Lasted 3 days. Localized ice.
Was given flu vaccine 10/2/12 (at flu clinic at their company). On 10/3/12 reported c/o chills, body aches & neck pain. Dry mouth after the injection. On 10/3/12 had H/A, dry mouth & joint pain. Nauseated. Temp 100.4. Instructed by our physician IBU, if no relief needs to be eval.
He doesn't feel well; Now he feels nauseated; He started with headache last week(beginning of August)/2 sides of his head and front part of the head hurts; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (He doesn't feel well), HEADACHE (He started with headache last week(beginning of August)/2 sides of his head and front part of the head hurts) and NAUSEA (Now he feels nauseated) in a 64-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In August 2021, the patient experienced HEADACHE (He started with headache last week(beginning of August)/2 sides of his head and front part of the head hurts). On an unknown date, the patient experienced MALAISE (He doesn't feel well) and NAUSEA (Now he feels nauseated). At the time of the report, MALAISE (He doesn't feel well) and NAUSEA (Now he feels nauseated) outcome was unknown and HEADACHE (He started with headache last week(beginning of August)/2 sides of his head and front part of the head hurts) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported No treatment medications were reported.
Information has been received from a pharmacist referring to a female patient of unknown age. Information regarding concurrent conditions and medical history was not provided. The pharmacist reported that the patient received her first dose of GARDASIL on an unspecified date one year ago (in 2014) and was in her pharmacy today, 27-JUL-2015, to receive dose number two (strength, dose, lot #, route and application site were not reported) (inappropriate schedule of drug administration). Concomitant therapy was not reported. No adverse experience reported. Additional information has been requested.
Second shot was worse; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Second shot was worse) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Second shot was worse). At the time of the report, VACCINATION COMPLICATION (Second shot was worse) outcome was unknown.            No concomitant medications were provided. No treatment medications were reported.   This case was linked to MOD-2021-351181, MOD-2021-351212 (Patient Link).   Reporter did not allow further contact